4//SEC Filing
Aggarwal Sumit 4
Accession 0001415889-21-005693
CIK 0001035354other
Filed
Dec 2, 7:00 PM ET
Accepted
Dec 3, 5:15 PM ET
Size
8.9 KB
Accession
0001415889-21-005693
Insider Transaction Report
Form 4
Aggarwal Sumit
Director
Transactions
- Exercise/Conversion
Restricted Stock Units
2021-12-01−279,158→ 0 total→ Common Stock (279,158 underlying) - Tax Payment
Common Stock
2021-12-01$0.72/sh−81,933$58,992→ 197,225 total - Exercise/Conversion
Common Stock
2021-12-01+279,158→ 279,158 total
Footnotes (3)
- [F1]The restricted stock units issued to the reporting person on April 1, 2021 have fully vested and settled for shares of the Issuer's common stock.
- [F2]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F3]The restricted stock units were issued pursuant to the Issuer's 2018 Equity Incentive Plan.
Documents
Issuer
Eloxx Pharmaceuticals, Inc.
CIK 0001035354
Entity typeother
Related Parties
1- filerCIK 0001854362
Filing Metadata
- Form type
- 4
- Filed
- Dec 2, 7:00 PM ET
- Accepted
- Dec 3, 5:15 PM ET
- Size
- 8.9 KB